Chimerism status is a useful predictor of relapse after allogeneic stem cell transplantation for acute leukemia
M Barrios, A Jiménez-Velasco, J Román-Gómez… - …, 2003 - haematologica.org
BACKGROUND AND OBJECTIVES: The role of hematopoietic chimerism after allogeneic
stem cell transplantation (SCT) for acute leukemia remains controversial. We studied the …
stem cell transplantation (SCT) for acute leukemia remains controversial. We studied the …
Chimerism analysis within 6 months of allogeneic stem cell transplantation predicts relapse in acute myeloid leukemia
C Huisman, RA De Weger, L De Vries… - Bone marrow …, 2007 - nature.com
The role of chimerism analysis as a prognostic indicator of relapse after hematopoietic stem
cell transplantation (SCT) is controversial. We monitored chimerism status by short tandem …
cell transplantation (SCT) is controversial. We monitored chimerism status by short tandem …
Quantitative chimerism: an independent acute leukemia prognosis indicator following allogeneic hematopoietic SCT
XY Qin, GX Li, YZ Qin, Y Wang, FR Wang… - Bone Marrow …, 2014 - nature.com
This study evaluates the prognostic significance of quantitative chimerism to monitor minimal
residual disease and predict relapse in acute leukemia (AL) patients following allogeneic …
residual disease and predict relapse in acute leukemia (AL) patients following allogeneic …
Reliable quantification of hematopoietic chimerism after allogeneic transplantation for acute leukemia using amplification by real-time PCR of null alleles and insertion …
A Jimenez-Velasco, M Barrios, J Roman-Gomez… - Leukemia, 2005 - nature.com
Increasing mixed chimerism (MC) after allogeneic stem cell transplantation (SCT) has been
associated with a high risk of relapse in acute leukemia. We evaluated a new method for …
associated with a high risk of relapse in acute leukemia. We evaluated a new method for …
Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT
P Bader, J Beck, A Frey, PG Schlegel… - Bone marrow …, 1998 - nature.com
Within a prospective study we analyzed hematopoietic chimerism in serial peripheral blood
samples taken from 55 patients with acute leukemias (ALL 21, AML 20, MDS 14) with a …
samples taken from 55 patients with acute leukemias (ALL 21, AML 20, MDS 14) with a …
[HTML][HTML] Chimerism studies with quantitative real-time PCR in stem cell recipients with acute myeloid leukemia
B Wiedemann, E Klyuchnikov, N Kröger… - Experimental …, 2010 - Elsevier
OBJECTIVE: Chimerism is well-established for surveillance of acute myeloid leukemia
(AML) patients after allogeneic hematopoietic stem cell transplantation (HSCT), but …
(AML) patients after allogeneic hematopoietic stem cell transplantation (HSCT), but …
Prognostic value of hematopoietic chimerism in patients with acute leukemia after allogeneic bone marrow transplantation: a prospective study
SJ Choi, KH Lee, JH Lee, S Kim, HJ Chung… - Bone marrow …, 2000 - nature.com
Hematopoietic chimerism as a predictive marker for the relapse of acute leukemia after
allogeneic BMT was evaluated in a prospective study. Monthly assays of hematopoietic …
allogeneic BMT was evaluated in a prospective study. Monthly assays of hematopoietic …
Leukemia lineage-specific chimerism analysis is a sensitive predictor of relapse in patients with acute myeloid leukemia and myelodysplastic syndrome after …
J Mattsson, M Uzunel, L Tammik, J Aschan, O Ringden - Leukemia, 2001 - nature.com
One of the major complications after allogeneic stem cell transplantation (SCT) in patients
with malignant disease is a high frequency of relapse. We have prospectively analyzed the …
with malignant disease is a high frequency of relapse. We have prospectively analyzed the …
[HTML][HTML] Mixed T lymphocyte chimerism after allogeneic hematopoietic transplantation is predictive for relapse of acute myeloid leukemia and myelodysplastic …
HC Lee, RM Saliba, G Rondon, J Chen… - Biology of Blood and …, 2015 - Elsevier
Chimerism testing after allogeneic hematopoietic stem cell transplantation (allo-HSCT) in
patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) …
patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) …
[HTML][HTML] Monitoring of donor chimerism in sorted CD34+ peripheral blood cells allows the sensitive detection of imminent relapse after allogeneic stem cell …
M Bornhäuser, U Oelschlaegel, U Platzbecker… - …, 2009 - ncbi.nlm.nih.gov
Abstract Analysis of donor chimerism is an important diagnostic tool to assess the risk of
relapse after allogeneic stem cell transplantation, especially in patients lacking a specific …
relapse after allogeneic stem cell transplantation, especially in patients lacking a specific …
相关搜索
- acute leukemia hematopoietic chimerism
- acute leukemia allogeneic transplantation
- acute leukemia useful predictor
- useful predictor chimerism status
- allogeneic transplantation hematopoietic chimerism
- relapse in patients chimerism analysis
- acute leukemias quantitative analysis
- donor chimerism imminent relapse
- acute leukemias pcr in patients
- prediction of relapse allogeneic bmt
- donor chimerism blood cells
- acute leukemia prognostic value
- sensitive predictor chimerism analysis
- sensitive predictor relapse in patients
- allogeneic transplantation reliable quantification
- allogeneic transplantation null alleles